ASSH 2008: SBi Successful in Chicago
The American Society for Surgery of the Hand held its 63rd Annual Meeting in Chicago from September 18th -20th. ASSH is dedicated to advancing the specialty of hand and upper extremity care. Over 2,500 hand surgeons, therapists, and other hand care professionals attended the meeting this year.
“The themes and technologies being addressed at this year’s ASSH conference have attracted a large international delegation, reflecting a broadening interest in best practices for treating millions with conditions such as arthritis,” said Anthony G. Viscogliosi, Chairman and CEO of SBi.
Small Bone Innovations, as one of the Elite Sponsors of ASSH, played an important role presenting its cutting-edge products.
SBi’s booth was again the largest, most dynamic exhibit and
featured the company’s Elbow Management System, Artelon®
Spacer suite for treating osteoarthritis in the thumb, SBi’s
Total Wrist Arthroplasty system and the Precise SD™ Distal
The products are fundamental to SBi’s strategy of providing surgeons with the widest and deepest anatomically focused portfolio in upper limb treatment. More than six hundred surgeons learned about SBi products over the three days they spent at the ASSH convention.
Below are the product demonstration workshops SBi offered this year:
- Total Wrist Arthroplasty as a Successful Treatment Option for Arthritis; Round-Table Discussion and Case Presentation
- Surface Replacement Arthroplasty of the PIP and MCP Joint as a Successful Treatment Option for Damaged and Arthritic Joints
- Variable Angle, Fixed Angle and Fracture Specific Plating for Simple to Complex Distal Radius Fractures
- A Complete Elbow Management System and Treatment Algorithm for Elbow Fractures
- Presenting a Surgical Implant Algorithmic Approach for Osteoarthritis of the CMC Joint
- Solutions to Chronic DRUJ Pain: Ulnar Head Replacement with Sigmoid Notch Resurfacing
SBi truly fulfilled and over exceeded the ‘Elite Sponsor’ Role and goals with successful product demonstration workshops and its highly dynamic booth.
SBi Received Award for Platinum Level Donor at AOFAS
SBi is the recipient of the Platinum Level Donor from the AOFAS Outreach & Education Fund, the American Orthopaedic Foot & Ankle Society.
The AOFAS Outreach & Education Fund (OEF) serves to preserve the AOFAS threefold mission: “to advance the educational opportunities, fund research and continue the tradition of service”. Through the support of SBi and many individual and corporate donors, the OEF has made great strides in the areas of education, research and humanitarian service.
Thomas Crowley, SBi President (center) receives the AOFAS Platinum Level Donor Award with Dr. Stephen Ross (Immediate Past President) (left), and Dr. Thomas Lee (right).
Red Herring Winner
SBi was a 2007 recipient of Red Herring magazine's annual "Red Herring 100 Global" award, recognized as one of the world's leading technology companies.
& Sullivan Award
Frost & Sullivan selected Small Bone Innovations (SBi), Inc.
as the recipient of the 2007 North American Frost & Sullivan
Award for Entrepreneurial Company of the Year. SBi, through its focus
on tissue-based and ‘life-altering’ treatment technologies,
has established their position in the $35 billion and still growing
Red Herring Winner
was a 2006 recipient of Red Herring magazine's annual "Red
Herring 100 North America" award, recognized as one of the nation's
leading technology companies and the only orthopedic device company
selected among an initial entry of more than one thousand firms.
$42.2 Million Series B Financing
completed a Series B financing, raising a record total of $42.2 million,
announced in January, 2006. Based on data provided by Venture Source,
this was the largest venture capital investment ever recorded in
the field of orthopedic devices.
50 Companies to Watch
Medical Device & Diagnostic
Industry Magazine named SBi to their list of “50 Companies
to Watch” in 2006, noting, “Small
Bone Innovations is going against the grain in its determination
to become a market leader in the small bone & joint device sector.”